Showing all 2 results
Trimetazidine Tablets
FreeProduct Composition & Strength
We supply this product as an advanced Modified-Release (MR) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the stability of both the active ingredient and the kinetic polymer matrix.
Active Ingredient Strength Primary Clinical Use Trimetazidine Dihydrochloride BP/Ph.Eur. 35 mg (Modified-Release) Global Standard: Twice-daily maintenance therapy for stable angina pectoris. Trimetazidine Dihydrochloride BP/Ph.Eur. 20 mg (Immediate-Release) Three-times-daily dosing for specialized dose titration or specific regional protocols. Excipients Hypromellose (HPMC) / Calcium Hydrogen Phosphate / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 12-hour kinetic release) Verapamil Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (Immediate Release) or Film Coated Tablets (Sustained Release – SR).
Active Ingredient Strength (Standard) Therapeutic Role Verapamil HCl USP/BP 40 mg / 80 mg Immediate Release (Arrhythmia) Verapamil HCl USP/BP 120 mg (SR) Sustained Release (Hypertension) Verapamil HCl USP/BP 240 mg (SR) High Dose / Once Daily Excipients Q.S. Sodium Alginate / HPMC SR Matrix Former
